![]() BMY In 3 months Estimated | Quarterly | $0.62 Per Share |
![]() BMY In 5 days Announced | Quarterly | $0.62 Per Share |
![]() BMY 2 months ago Paid | Quarterly | $0.62 Per Share |
![]() BMY 5 months ago Paid | Quarterly | $0.6 Per Share |
![]() BMY 8 months ago Paid | Quarterly | $0.6 Per Share |
![]() BMY 11 months ago Paid | Quarterly | $0.6 Per Share |
25 Apr 2025 (26 Days) Date | | 1.53 Cons. EPS | - EPS |
6 Feb 2025 Date | | 1.47 Cons. EPS | 1.67 EPS |
31 Oct 2024 Date | | 1.49 Cons. EPS | 1.8 EPS |
26 Jul 2024 Date | | 1.63 Cons. EPS | 2.07 EPS |
7 May 2024 Date | | - Cons. EPS | - EPS |
![]() BMY In 3 months Estimated | Quarterly | $0.62 Per Share |
![]() BMY In 5 days Announced | Quarterly | $0.62 Per Share |
![]() BMY 2 months ago Paid | Quarterly | $0.62 Per Share |
![]() BMY 5 months ago Paid | Quarterly | $0.6 Per Share |
![]() BMY 8 months ago Paid | Quarterly | $0.6 Per Share |
![]() BMY 11 months ago Paid | Quarterly | $0.6 Per Share |
25 Apr 2025 (26 Days) Date | | 1.53 Cons. EPS | - EPS |
6 Feb 2025 Date | | 1.47 Cons. EPS | 1.67 EPS |
31 Oct 2024 Date | | 1.49 Cons. EPS | 1.8 EPS |
26 Jul 2024 Date | | 1.63 Cons. EPS | 2.07 EPS |
7 May 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - General Industry | Healthcare Sector | Dr. Christopher S. Boerner Ph.D. CEO | NYSE Exchange | US1101221083 ISIN |
Germany Country | - Employees | 4 Apr 2025 Last Dividend | 7 Aug 2001 Last Split | - IPO Date |
Bristol-Myers Squibb Company is an eminent global biopharmaceutical firm engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of innovative biopharmaceutical products. With a spectrum of treatments covering hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases, the company has established a significant footprint in the healthcare sector. Initially founded as Bristol-Myers Company in 1887, it has evolved over the decades to become a leader in the biopharmaceutical industry, headquartered in Princeton, New Jersey. The company's operational reach spans globally, selling products through a diversified channel mix including wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies.